Mikhail V. Pashenkov

Dr. Mikhail V. Pashenkov


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2018 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
MPMikhail V. Pashenkov
Mikhail V. Pashenkov
NMNina E Murugina
Nina E Murugina
ABAnna S. Budikhina
Anna S. Budikhina
BPBoris V. Pinegin
Boris V. Pinegin

1 January 2018 in International Immunopharmacology
Verified
Journal Article
Closed access
MPMikhail V. Pashenkov
Mikhail V. Pashenkov
YDYulia A. Dagil
Yulia A. Dagil
BPBoris V. Pinegin
Boris V. Pinegin

1 March 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
NMNina E. Murugina
Nina E. Murugina
ABAnna S. Budikhina
Anna S. Budikhina
YDYulia A. Dagil
Yulia A. Dagil
PMPolina V. Maximchik
Polina V. Maximchik
LBLyudmila S. Balyasova
Lyudmila S. Balyasova
MPMikhail V. Pashenkov
Mikhail V. Pashenkov
Upon activation with pathogen-associated molecular patterns, metabolism of macrophages and dendritic cells is shifted from oxidative phosphorylation to aerobic glycolysis, which is considered important for proinflammatory cytokine production. Fragments of bacterial peptidoglycan (muramyl peptides) activate innate immune cells through nucleotide-binding oligomerization domain (NOD) 1 and/or NOD2 receptors. Here, we show that NOD1 and NOD2 agonists induce early glycolytic reprogramming of human monocyte-derived macrophages (MDM), which is similar to that induced by the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide. This glycolytic reprogramming depends on Akt kinases, independent of mTOR complex 1 and is efficiently inhibited by 2-deoxy-d-glucose (2-DG) or by glucose starvation. 2-DG inhibits proinflammatory cytokine production by MDM and monocyte-derived dendritic cells activated by NOD1 or TLR4 agonists, except for tumor necrosis factor production by MDM, which is inhibited initially, but augmented 4 h after addition of agonists and later. However, 2-DG exerts these effects by inducing unfolded protein response rather than by inhibiting glycolysis. By contrast, glucose starvation does not cause unfolded protein response and, in normoxic conditions, only marginally affects proinflammatory cytokine production triggered through NOD1 or TLR4. In hypoxia mimicked by treating MDM with oligomycin (a mitochondrial ATP synthase inhibitor), both 2-DG and glucose starvation strongly suppress tumor necrosis factor and interleukin-6 production and compromise cell viability. In summary, the requirement of glycolytic reprogramming for proinflammatory cytokine production in normoxia is not obvious, and effects of 2-DG on cytokine responses should be interpreted cautiously. In hypoxia, however, glycolysis becomes critical for cytokine production and cell survival.

11 August 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YDYulia A. Dagil
Yulia A. Dagil
NANikolai P. Arbatsky
Nikolai P. Arbatsky
BABiana I. Alkhazova
Biana I. Alkhazova
VLVyacheslav L. L’vOv
Vyacheslav L. L’vOv
DMDmitriy V. Mazurov
Dmitriy V. Mazurov
MPMikhail V. Pashenkov
Mikhail V. Pashenkov
Muropeptides are fragments of peptidoglycan that trigger innate immune responses by activating nucleotide-binding oligomerization domain (NOD) 1 and NOD2. Muropeptides from Gram-negative bacteria contain a meso-diaminopimelic acid (meso-DAP) residue in either a terminal or a non-terminal position. While the former ones are known to be recognized by NOD1, much less is known about recognition of muropeptides with non-terminal meso-DAP, which are most abundant moieties of Gram-negative peptidoglycans. Here, we developed a novel system to assess biological activity of muropeptides, based on CRISPR/Cas9-mediated knockout (KO) of NOD1 and NOD2 genes in modified HEK293T cells. Using NOD1/NOD2 knockout and overexpression systems, as well as human monocytes and macrophages, we refine the current view of muropeptide recognition. We show that NOD2 can recognize different natural muropeptides containing a meso-DAP residue (preferably in a non-terminal position), provided they are present at micromolar concentrations. NOD2 accepts muropeptides with long and branched peptide chains and requires an intact N-acetylmuramyl residue. Muropeptides with non-terminal meso-DAP can activate NOD1 as well, but, in this case, probably require peptidase pre-processing to expose the meso-DAP residue. Depending on NOD1/NOD2 ratio in specific cell types, meso-DAP-containing muropeptides can be recognized either primarily via NOD2 (in monocytes) or via NOD1 (in monocyte-derived macrophages and HEK293T-derived cells). The dual NOD1/NOD2 agonism of meso-DAP-containing muropeptides should be taken into account when assessing cellular responses to muropeptides and designing muropeptide immunostimulants and vaccine adjuvants.

6 July 2011 in Clinical and Vaccine Immunology
Verified
Journal Article
Closed access
PDF file
VMVladimir V. Murugin
Vladimir V. Murugin
IZIrina N. Zuikova
Irina N. Zuikova
NMNina E. Murugina
Nina E. Murugina
ASAndrey E. Shulzhenko
Andrey E. Shulzhenko
BPBoris V. Pinegin
Boris V. Pinegin
MPMikhail V. Pashenkov
Mikhail V. Pashenkov
NK cells lyse virus-infected cells by degranulation; however, alterations in NK cell degranulation in persistent viral infections have not been directly studied. Earlier reports have documented a decrease in NK activity in patients with frequently recurring herpes (FRH). We corroborate these findings by showing that the degranulation responses of blood NK cells from patients with FRH, both during relapse and during remission, are significantly lower than those in healthy donors. The impaired degranulation was probably not caused by defective target cell recognition, since it was observed upon stimulation both with K562 cells and with a receptor-independent stimulus (phorbol 12-myristate 13-acetate plus ionomycin). We also show that the intracellular expression of perforin and CD107a by NK cells from patients with FRH is not different from that in healthy donors, thus excluding that the low NK cell degranulation in FRH is caused by a smaller size of the lytic granule compartment. We confirm previous reports on lowered NK activity in FRH patients and show that NK activity is significantly impaired only during remission, but not relapse; the causes for the discrepancy between the low degranulation and “normal” NK cell activity during relapse are discussed. In all, these data point at the deficit of NK cell degranulation in FRH. Whether this is a predisposing factor or a consequence of herpes simplex virus infection requires further investigation.

15 February 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MPMikhail V. Pashenkov
Mikhail V. Pashenkov
LBLyudmila S. Balyasova
Lyudmila S. Balyasova
YDYulia A Dagil
Yulia A Dagil
BPBoris V. Pinegin
Boris V. Pinegin
Activation of nucleotide-binding oligomerization domain (NOD) 1 and NOD2 by muropeptides triggers a complex transcriptional program in innate immune cells. However, little is known about posttranscriptional regulation of NOD1- and NOD2-dependent responses. When stimulated with a prototypic NOD1 agonist, N-acetylglucosaminyl–N-acetylmuramyl–l-alanyl-d-isoglutamyl-meso-diaminopimelic acid (GM-triDAP), human monocyte-derived macrophages (MDM) produced an order of magnitude more TNF, IL-6, and pro–IL-1β than did monocyte-derived dendritic cells (MDDC), despite similar NOD1 expression, similar cytokine mRNA kinetics, and comparable responses to LPS. TNF production by GM-triDAP–activated MDM was independent of autocrine IL-1. However, GM-triDAP–activated MDM translated TNF mRNA more efficiently than did MDDC. As an underlying mechanism, NOD1 triggering in MDM caused a more potent and long-lasting activation of the signaling axis involving p38 MAPK, MAPK-interacting kinase (MNK), and eukaryotic translation initiation factor 4E, which is a critical regulator of translation. Furthermore, MNK controlled TNF mRNA abundance in MDDC and MDM upon NOD1 triggering. NOD1-dependent responses were more sensitive to MNK inhibition than were TLR4-dependent responses. These results demonstrate the importance of the p38–MNK–eukaryotic translation initiation factor 4E axis in TNF production downstream of NOD1.